Scripps Research Joins AbbVie In Deal For Cancer Immunotherapy.

The San Diego Union-Tribune (6/24, Fikes) reports the Scripps Research Institute recently reached a “a major deal with pharma giant AbbVie for its improved version of an immune therapy for cancer,” and although the financial details were not disclosed, “...